Deutsche Bank’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,047
| Closed | -$267K | – | 4618 |
|
|
2020
Q3 | $267K | Buy |
5,047
+310
| +7% | +$19.1K | ﹤0.01% | 3049 |
|
|
2020
Q2 | $290K | Buy |
4,737
+830
| +21% | +$48K | ﹤0.01% | 2930 |
|
|
2020
Q1 | $221K | Buy |
3,907
+243
| +7% | +$13.8K | ﹤0.01% | 2901 |
|
|
2019
Q4 | $207K | Buy |
3,664
+1,316
| +56% | +$69.8K | ﹤0.01% | 3204 |
|
|
2019
Q3 | $124K | Sell |
2,348
-34,100
| -94% | -$1.99M | ﹤0.01% | 3442 |
|
|
2019
Q2 | $2.17M | Sell |
36,448
-9,666
| -21% | -$608K | ﹤0.01% | 2335 |
|
|
2019
Q1 | $2.87M | Buy |
46,114
+38,526
| +508% | +$2.55M | ﹤0.01% | 2234 |
|
|
2018
Q4 | $459K | Sell |
7,588
-8,374
| -52% | -$500K | ﹤0.01% | 3394 |
|
|
2018
Q3 | $933K | Sell |
15,962
-24,544
| -61% | -$1.25M | ﹤0.01% | 3380 |
|
|
2018
Q2 | $1.82M | Sell |
40,506
-777
| -2% | -$33.4K | ﹤0.01% | 3022 |
|
|
2018
Q1 | $1.83M | Buy |
41,283
+9,126
| +28% | +$383K | ﹤0.01% | 2923 |
|
|
2017
Q4 | $1.39M | Buy |
32,157
+6,709
| +26% | +$302K | ﹤0.01% | 2980 |
|
|
2017
Q3 | $1.18M | Sell |
25,448
-4,180
| -14% | -$200K | ﹤0.01% | 2894 |
|
|
2017
Q2 | $1.47M | Buy |
29,628
+28,179
| +1,945% | +$1.48M | ﹤0.01% | 2760 |
|
|
2017
Q1 | $78K | Sell |
1,449
-6,769
| -82% | -$358K | ﹤0.01% | 4028 |
|
|
2016
Q4 | $456K | Buy |
8,218
+6,353
| +341% | +$305K | ﹤0.01% | 3226 |
|
|
2016
Q3 | $84K | Sell |
1,865
-2,431
| -57% | -$97.6K | ﹤0.01% | 4007 |
|
|
2016
Q2 | $170K | Sell |
4,296
-9,948
| -70% | -$364K | ﹤0.01% | 3854 |
|
|
2016
Q1 | $495K | Sell |
14,244
-434
| -3% | -$15.9K | ﹤0.01% | 3222 |
|
|
2015
Q4 | $629K | Buy |
14,678
+13,326
| +986% | +$668K | ﹤0.01% | 3167 |
|
|
2015
Q3 | $58K | Sell |
1,352
-7,325
| -84% | -$395K | ﹤0.01% | 4376 |
|
|
2015
Q2 | $447K | Buy |
8,677
+913
| +12% | +$38.9K | ﹤0.01% | 3464 |
|
|
2015
Q1 | $303K | Buy |
7,764
+7,709
| +14,016% | +$302K | ﹤0.01% | 3580 |
|
|
2014
Q4 | $2K | Buy |
55
+19
| +53% | +$725 | ﹤0.01% | 6029 |
|
|
2014
Q3 | $1K | Sell |
36
-200
| -85% | -$5.87K | ﹤0.01% | 5809 |
|
|
2014
Q2 | $5K | Sell |
236
-562
| -70% | -$14.6K | ﹤0.01% | 5633 |
|
|
2014
Q1 | $20K | Buy |
798
+782
| +4,888% | +$18.7K | ﹤0.01% | 4847 |
|
|
2013
Q4 | $0 | Sell |
16
-6,705
| -100% | -$137K | ﹤0.01% | 5814 |
|
|
2013
Q3 | $130K | Sell |
6,721
-10,120
| -60% | -$179K | ﹤0.01% | 4315 |
|
|
2013
Q2 | $262K | Buy |
+16,841
| New | +$271K | ﹤0.01% | 3642 |
|
Other funds holding BSTC
Deutsche Bank's BSTC Position: Q4 2020 in Review
Deutsche Bank sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 5,047 shares — an estimated $267K sold.
Deutsche Bank first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $2.87M in Q1 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Deutsche Bank reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Deutsche Bank sold 5,047 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $267K.
- Deutsche Bank first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Deutsche Bank's BioSpecifics Technologies Corp. position peaked at $2.87M in Q1 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.